Sixteen U.S. senators today urged the Department of Health and Human Services to take immediate action to reduce the price of naloxone – a drug that can be delivered via nasal mist or injection to temporarily suspend the effects of an overdose until emergency responders arrive. “No police officer, no firefighter, no public health provider, and no person should be unable to save a life because of the high price,” the senators wrote to HHS Secretary Alex Azar. “By bringing down the cost, we can get this life-saving drug in the hands of more people as called for by the Surgeon General. Doing so will save countless lives.” Earlier this month, U.S. Surgeon General Jerome Adams, M.D., issued a public health advisory urging Americans who misuse opioids, have an opioid use disorder or recent overdose, or know someone who does, to carry and know how to use naloxone.

Related News Articles

Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
The AHA, American Medical Association, American Society of Anesthesiologists, American Society of Health-System Pharmacists, and Association for Clinical…
Headline
Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D…
Headline
Mallinckrodt Pharmaceuticals today announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in…
Headline
Public and private entities can apply for $1 million grants for a three-year period to enhance or expand opioid and other substance use disorder services in…